GeneDx Holdings Corp. (WGS) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $105.00M | +23.2% |
| 2024 | $85.21M | -14.5% |
| 2023 | $99.68M | -19.6% |
| 2022 | $123.93M | -69.1% |
| 2021 | $400.57M | +270.4% |
| 2020 | $108.13M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $105.00M | +23.2% |
| 2024 | $85.21M | -14.5% |
| 2023 | $99.68M | -19.6% |
| 2022 | $123.93M | -69.1% |
| 2021 | $400.57M | +270.4% |
| 2020 | $108.13M | — |